Clinical Trials Browser

Phase 2 × INDUSTRY × Pancreatic Diseases × Clear all

Digestive System Diseases, Digestive System Neoplasms, Pancreatic Diseases, Pancreatic Neoplasms

NCT03717298 2023-03-28

Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma

Digestive System Diseases, Digestive System Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Pancreatic Diseases, Pancreatic Neoplasms

NCT03188991 2021-06-14

Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms

Phase 2 Completed

20 enrolled 13 charts

Gastrointestinal

Digestive System Neoplasms, Pancreatic Cyst, Pancreatic Diseases, Pancreatic Neoplasms

NCT01608711 2017-05-16

A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002

Phase 2 Completed

2 enrolled

Gastrointestinal

Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT00902291 2015-09-14

A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer

Phase 2 Completed

205 enrolled

Gastrointestinal

Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

Clinical Trials

Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma

Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma

Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms

A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002

A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer